待切除肝叶的术前胆道引流不影响经皮经肝门静脉栓塞后的肝肥大
本研究回顾性分析76例接受经皮经肝门静脉栓塞(PVE)的恶性肝门部胆道狭窄患者,比较仅引流未来残肝(A组29例)与双侧引流包括待切除肝叶(B组47例)对PVE后肝肥大的影响。结果显示两组未来残肝比率与肝肥大比率均无显著差异,提示对引流不佳的患者可接受对待切除肝叶追加术前胆道引流。
要点
- 待切除肝叶的术前胆道引流未降低PVE后未来残肝比率。
- 待切除肝叶的术前胆道引流未降低PVE后肝肥大比率。
- 对胆道引流不佳者,可考虑对待切除肝叶追加引流。
核心结论
- 待切除肝叶的术前胆道引流未降低PVE后未来残肝比率和肝肥大比率。
研究设计与样本
- 回顾性研究,纳入2008年1月至2017年12月本院169例恶性肝门部胆道狭窄行大范围肝切除或姑息手术患者中的76例接受PVE者。
- A组29例仅行未来残肝单侧术前胆道引流,B组47例行双侧引流包括待切除肝叶。
主要发现
- B组胆道狭窄显著更严重(p=0.0038),胆道引流前血清胆红素显著更高(p=0.0037)。
- PVE后总肝体积分别为1287±260 ml和1340±257 ml(p=0.39),未来残肝体积分别为555±135 ml和577±113 ml(p=0.45)。
- 未来残肝比率分别为43.4±8.2%和43.4±6.4%(p=0.98),肝肥大比率分别为124.2±17.7%和129.2±20.9%(p=0.28)。
- 排除Bismuth I型患者后分析获得相似结果。
临床怎么用
- 在胆道引流不佳的恶性肝门部胆道狭窄患者中,可接受对待切除肝叶追加术前胆道引流。
局限性
- 本研究为单中心回顾性研究,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In patients with malignant perihilar biliary strictures, preoperative biliary drainage (PBD) of the hepatic lobe to be resected may decrease the liver volume of the future liver remnant (FLR) after percutaneous transhepatic portal vein embolization (PVE). However, evidence of its application is insufficient. This study aimed to clarify the effects of PBD on liver hypertrophy after PVE. METHODS: Between January 2008 and December 2017, 169 patients with malignant perihilar biliary strictures underwent major hepatectomy or palliative surgery at our hospital. Of these, 76 patients who underwent PVE were categorized into two groups: group A (n = 29) who received unilateral PBD of the FLR and group B (n = 47) who received bilateral PBD, including that of the hepatic lobe to be resected. FLR ratios after PVE and liver hypertrophy ratios were retrospectively compared in both groups. RESULTS: Group B exhibited significantly severe biliary stenosis (p = 0.0038) and high serum bilirubin before biliary drainage (p = 0.0037). After PVE, the total liver volumes were 1287 ± 260 ml and 1340 ± 257 ml (p = 0.39), respectively. FLR volumes were 555 ± 135 and 577 ± 113 ml (p = 0.45), respectively. FLR ratios were 43.4 ± 8.2% and 43.4 ± 6.4%, respectively (p = 0.98). Liver hypertrophy ratios were 124.2 ± 17.7% and 129.2 ± 20.9%, respectively (p = 0.28). In addition, an examination which excluded patients with Bismuth type I obtained similar result. CONCLUSIONS: PBD of the hepatic lobe to be resected did not decrease the FLR ratios and hypertrophy ratios. Thus, in patients with poor biliary drainage, additional PBD of the target lobe is acceptable.
引用
- Miura S, Kanno A, Fukase K, et al. Preoperative biliary drainage of the hepatic lobe to be resected does not affect liver hypertrophy after percutaneous transhepatic portal vein embolization. Surg Endosc. 2019. PMID: 31062157. doi:10.1007/s00464-019-06813-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。